Dyadic (AMEX:DIL)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Dyadic Charts. Click Here for more Dyadic Charts.](/p.php?pid=staticchart&s=A%5EDIL&p=8&t=15)
Dyadic International, Inc. (AMEX:DIL), a biotechnology
company, announced today that Dyadic scientist Marco Baez, Ph.D., will
make a presentation at the International Distillers Grains Conference
(IDGC) to be held at the Hyatt Regency Hotel in Minneapolis, MN, on
September 12-14, 2006. Dr. Baez's presentation is scheduled for
September 14 at 8:30 a.m. CDT (9:30 a.m. EDT). Presentation slides
will be available at the Company's website at http://www.dyadic.com.
Dr. Baez will participate on the panel entitled "Beyond Feed:
Alternative Uses for Distillers Grains." Dr. Baez plans to discuss the
Company's progress in the development of enzymes to convert cellulose
and hemicellulose, which comprise as much as half the weight of Dried
Distillers Grains (DDGs), to fermentable sugars. These additional
sugars can be utilized to produce more ethanol from the same amount of
corn.
"Dyadic has spent over a decade of R&D in the design and
development of enzymes for the increasingly efficient extraction of
sugars from biomass, including a two year collaboration on DDGs with
the Iowa Corn Promotion Board under a Department of Energy grant. We
are using our proprietary technologies to develop enzyme mixtures that
will increase yields and reduce the costs of the corn-to-ethanol
process," Dr. Baez said. "This is a huge market opportunity for
Dyadic, as production of corn-based ethanol in the U.S. alone is
expected to increase from about 4.7 billion gallons in 2006 to at
least 12 billion gallons by 2012. We believe that more efficient
extraction of sugars from DDGs has the potential to increase the
productivity of the corn ethanol manufacturing process by 10 to 20%.
This could translate into billions of dollars of additional ethanol
revenue every year."
Hosted by Distillers Grains Quarterly and facilitated by the
magazine's publisher, BBI International, the IDGC is exclusively
focused on industry issues related to distillers grains produced at
U.S. dry mill ethanol plants. More information about the conference is
available at the conference website at
http://www.distillersgrainsconference.com/
About Dyadic
Dyadic International, Inc., based in Jupiter, Florida, with
operations in the United States of America, Hong Kong and mainland
China, Poland and The Netherlands, is engaged in the development,
manufacture and sale of biological products using a number of
proprietary fungal strains to produce enzymes and other biomaterials,
principally focused on a system for protein production based on the
patented Chrysosporium lucknowense fungus, known as C1. Dyadic is
applying its technologies to produce enzymes for use in converting
various agricultural products (e.g. corn) and waste products (e.g.
switch grass, wheat straw, sugar cane bagasse, etc.) into fermentable
sugars, which can then be used in the production of traditional and
cellulosic ethanol as well as other products currently derived from
petroleum. Dyadic's C1 technology also is being developed to
facilitate the discovery, development and large-scale production of
human antibodies and other high-value therapeutic proteins. Dyadic
currently sells more than 45 liquid and dry enzyme products to more
than 200 industrial customers in approximately 50 countries for the
textile, pulp & paper, animal feed, alcohol, starch, and food and
beverage industries.
Cautionary Statement for Forward-Looking Statements
Certain statements contained in this press release are
"forward-looking statements." These forward-looking statements involve
risks and uncertainties that could cause our actual results,
performance or achievements to be materially different from any future
results, performance or achievements expressed or implied by such
forward-looking statements. For a discussion of these risks and
uncertainties, please see our filings from time to time with the
Securities and Exchange Commission, which are available free of charge
on the SEC's web site at http://www.sec.gov, including our Annual
Report on Form 10-KSB for the year ended December 31, 2005, and our
subsequent filings with the SEC. Except as required by law, we
expressly disclaim any intent or obligation to update any
forward-looking statements.